TheALKtranslocation in advanced non‐small‐cell lung carcinomas: preapproval testing experience at a single cancer centre-Reference-Cited by-同舟云学术

TheALKtranslocation in advanced non‐small‐cell lung carcinomas: preapproval testing experience at a single cancer centre

Published:2013-02-05 Issue:4 Volume:62 Page:609-616
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Conde Esther¹,Angulo Bárbara¹,Izquierdo Elisa¹,Muñoz Luna¹,Suárez‐Gauthier Ana¹,Plaza Carlos¹,Dominguez Nuria¹,Torres Maribel²,Madrigal Luis³,Rubio‐Viqueira Belén⁴,Belda‐Iniesta Cristobal⁴,Hidalgo Manuel⁴,López‐Ríos Fernando¹

Affiliation:

1. Laboratorio de Dianas Terapéuticas Centro Integral Oncológico ‘Clara Campal’, Hospital Universitario Madrid Sanchinarro Universidad San Pablo‐CEU MadridSpain

2. Radiology Department Hospital Universitario Madrid Sanchinarro Universidad San Pablo‐CEU Madrid Spain

3. Thoracic Surgery Department Hospital Universitario Madrid Sanchinarro Universidad San Pablo‐CEU Madrid Spain

4. Oncology Department Centro Integral Oncológico ‘Clara Campal’, Hospital Universitario Madrid Sanchinarro Universidad San Pablo‐CEU Madrid Spain

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.12037

Reference46 articles.

1. Incorporation of Crizotinib into the NCCN Guidelines

2. Biology-driven medicine: tissue matters

3. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

4. The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma;Translational Lung Cancer Research;2023-07

2. Caracterización y clasificación molecular del cáncer de pulmón;Revisiones en Cáncer;2023

3. Determination of the target population in early benefit assessments in Germany: challenges for non-small-cell lung cancer;The European Journal of Health Economics;2020-03-31

4. Hibridación in situ fluorescente (FISH) en el Instituto Nacional de Cancerología (INC) de Colombia. Experiencia de 5 años;Revista Colombiana de Cancerología;2019-02-13

5. A consensus statement on the gender perspective in lung cancer;Clinical and Translational Oncology;2016-11-24